Close Menu

NEW YORK (GenomeWeb) – Akonni Biosystems announced today that it has received a $300,000 grant from the National Institutes of Health to finalize development of a rapid, point-of-care tuberculosis assay for use on the company's TruDx 3000 sample-to-answer diagnostic system.

The grant was awarded under the NIH's Commercialization Readiness Pilot program, which is designed to help small businesses transition projects previously funded by the agency into the commercialization stage.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.